Nissay Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,422
| Closed | -$590K | – | 703 |
|
|
2025
Q1 | $590K | Buy |
2,422
+28
| +1% | +$6.82K | ﹤0.01% | 668 |
|
|
2024
Q4 | $792K | Sell |
2,394
-87
| -4% | -$28.8K | ﹤0.01% | 669 |
|
|
2024
Q3 | $830K | Buy |
2,481
+63
| +3% | +$21.1K | 0.01% | 669 |
|
|
2024
Q2 | $660K | Sell |
2,418
-105
| -4% | -$28.7K | ﹤0.01% | 683 |
|
|
2024
Q1 | $873K | Buy |
2,523
+44
| +2% | +$15.2K | 0.01% | 663 |
|
|
2023
Q4 | $800K | Buy |
2,479
+71
| +3% | +$22.9K | 0.01% | 655 |
|
|
2023
Q3 | $863K | Buy |
2,408
+82
| +4% | +$29.4K | 0.01% | 641 |
|
|
2023
Q2 | $882K | Sell |
2,326
-70
| -3% | -$26.5K | 0.01% | 640 |
|
|
2023
Q1 | $1.15M | Sell |
2,396
-84
| -3% | -$40.2K | 0.01% | 575 |
|
|
2022
Q4 | $1.04M | Sell |
2,480
-55
| -2% | -$23.1K | 0.01% | 588 |
|
|
2022
Q3 | $1.06M | Buy |
2,535
+104
| +4% | +$43.4K | 0.01% | 576 |
|
|
2022
Q2 | $1.2M | Buy |
2,431
+36
| +2% | +$17.8K | 0.01% | 545 |
|
|
2022
Q1 | $1.35M | Buy |
2,395
+70
| +3% | +$39.4K | 0.01% | 559 |
|
|
2021
Q4 | $1.76M | Buy |
2,325
+11
| +0.5% | +$8.31K | 0.01% | 514 |
|
|
2021
Q3 | $1.73M | Buy |
2,314
+95
| +4% | +$70.9K | 0.01% | 495 |
|
|
2021
Q2 | $1.43M | Sell |
2,219
-139
| -6% | -$89.6K | 0.01% | 540 |
|
|
2021
Q1 | $1.35M | Sell |
2,358
-38
| -2% | -$21.7K | 0.01% | 538 |
|
|
2020
Q4 | $1.4M | Buy |
2,396
+26
| +1% | +$15.2K | 0.02% | 511 |
|
|
2020
Q3 | $1.22M | Buy |
2,370
+26
| +1% | +$13.4K | 0.02% | 480 |
|
|
2020
Q2 | $1.06M | Buy |
2,344
+244
| +12% | +$110K | 0.02% | 505 |
|
|
2020
Q1 | $736K | Buy |
2,100
+82
| +4% | +$28.7K | 0.02% | 499 |
|
|
2019
Q4 | $747K | Buy |
+2,018
| New | +$747K | 0.02% | 597 |
|